Advances in our understanding of the molecular mechanisms of action of cisplatin in cancer therapy

PB Tchounwou, S Dasari, FK Noubissi… - Journal of …, 2021 - Taylor & Francis
Cisplatin and other platinum-based chemotherapeutic drugs have been used extensively for
the treatment of human cancers such as bladder, blood, breast, cervical, esophageal, head …

Cisplatin in ovarian cancer treatment—known limitations in therapy force new solutions

A Zoń, I Bednarek - International journal of molecular sciences, 2023 - mdpi.com
Cisplatin is one of the most commonly used anticancer drugs worldwide. It is mainly used in
the treatment of ovarian cancer, but also used in testicular, bladder and lung cancers. The …

Lipid-laden lung mesenchymal cells foster breast cancer metastasis via metabolic reprogramming of tumor cells and natural killer cells

Z Gong, Q Li, J Shi, ET Liu, LD Shultz, G Ren - Cell metabolism, 2022 - cell.com
While the distant organ environment is known to support metastasis of primary tumors, its
metabolic roles in this process remain underdetermined. Here, in breast cancer models, we …

Cisplatin for cancer therapy and overcoming chemoresistance

R Ranasinghe, ML Mathai, A Zulli - Heliyon, 2022 - cell.com
Cisplatin spearheads the anticancer chemotherapeutics in present-day use although acute
toxicity is its primary impediment factor. Among a plethora of experimental medications, a …

Tumor-targeted exosomes for delivery of anticancer drugs

R Raguraman, D Bhavsar, D Kim, X Ren, V Sikavitsas… - Cancer letters, 2023 - Elsevier
Exosomes are small phospholipid bilayer vesicles that are naturally produced by all living
cells, both prokaryotes and eukaryotes. The exosomes due to their unique size, reduced …

Bioactivity and development of small non-platinum metal-based chemotherapeutics

MG Ferraro, M Piccolo, G Misso, R Santamaria, C Irace - Pharmaceutics, 2022 - mdpi.com
Countless expectations converge in the multidisciplinary endeavour for the search and
development of effective and safe drugs in fighting cancer. Although they still embody a …

[HTML][HTML] Global burden of ototoxic hearing loss associated with platinum-based cancer treatment: A systematic review and meta-analysis

LK Dillard, L Lopez-Perez, RX Martinez… - Cancer …, 2022 - Elsevier
Platinum-based chemotherapeutic agents cisplatin and carboplatin are widely used in
cancer treatment worldwide and may result in ototoxic hearing loss. The high incidence of …

[HTML][HTML] Nasal administration of mitochondria reverses chemotherapy-induced cognitive deficits

JF Alexander, AV Seua, LD Arroyo, PR Ray… - Theranostics, 2021 - ncbi.nlm.nih.gov
Up to seventy-five percent of patients treated for cancer suffer from cognitive deficits which
can persist for months to decades, severely impairing quality of life. Although the number of …

Second and third-row transition metal compounds containing benzimidazole ligands: An overview of their anticancer and antitumour activity

GV Suárez-Moreno, D Hernández-Romero… - Coordination Chemistry …, 2022 - Elsevier
The application of metal compounds in the medical field dates back to the XVI century with
some isolated reports about the therapeutic importance of metals and their compounds in …

Multiplexed live-cell profiling with Raman probes

C Chen, Z Zhao, N Qian, S Wei, F Hu, W Min - Nature Communications, 2021 - nature.com
Single-cell multiparameter measurement has been increasingly recognized as a key
technology toward systematic understandings of complex molecular and cellular functions in …